Use of Non-Contact Sensors for the Medical Industry

	Medical Device
	The latest medical device news from News Medical

Countless processes and treatments of the modern medical industry require careful monitoring with the help of highly technological devices. For such devices, whether handling bodily fluids or external medications, levels of these substances must be sensed and measured accurately.

To this end, a special sensor can accommodate many device sizes while taking accurate notes of the levels of substances like blood, insulin, and IV fluids. As the name indicates, a non-contact level sensor never touches the substances being monitored in a vessel or tube, nor does the ultrasonic signal affect the given fluid, maintaining hygiene and quality.

Read the Article

			Time of radiotherapy influences cancer treatment response A team of researchers from the Andalusian Centre for Molecular Biology and Regenerative Medicine (CABIMER) and the University of Seville, in collaboration with the Virgen Macarena University Hospital, have identified a fundamental mechanism that links the 24-hour circadian cycle to the precise repair of DNA breaks.

			M-PACT sets new standard for pediatric brain tumor diagnostics, treatment monitoring Liquid biopsies, which test body fluids that contain cancerous material, including circulating tumor DNA (ctDNA), are a noninvasive way to learn about a cancer's biology.

	Advanced use of MRI aids in accurate identification of rare, atypical parkinsonian disorders An international study led by researchers from the Sant Pau Research Institute (IR Sant Pau) shows that advanced use of magnetic resonance imaging (MRI) allows much more accurate identification of patients with progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD).

	Study examines the effectiveness of urine testing as a screening tool for alcohol use in pregnancy Previous reports have indicated that between 20 and 60 per cent of pregnant women in Ireland consume alcohol during pregnancy.

	Breast screening associated with better ten-year survival in stage IV cancer Women with stage IV breast cancer detected through screening have a 60% chance of survival ten years after diagnosis.

	Low-field MRI could offer an alternative to existing breast cancer screening methods Mass General Brigham's evaluation of low-field MRI performance lays potential groundwork for this technology to be a lower-cost, accessible option for breast imaging.

	DeepRare AI helps shorten the rare disease diagnostic journey with evidence-linked predictions Researchers developed DeepRare, an LLM-driven multi-agent diagnostic system that integrates clinical descriptions, phenotype data, and genomic information to improve rare disease identification. Across thousands of cases, the system showed higher diagnostic recall than existing AI tools and clinicians in benchmark testing, while providing traceable reasoning linked to medical evidence.

	New Pico C technology maps genome structure before activation For decades, scientists viewed the genome of a newly fertilised egg as a structural 'blank slate' – a disordered tangle of DNA waiting for the embryo to 'wake up' and start reading its own genetic instructions.

How would you rate today's newsletter?

Stay updated with the latest in health and medical news! Follow News‑Medical.net on Google News for real‑time updates. Click here to follow us now.

Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd.,

Manchester | Sydney | Boston

Copyright © 2000-2026